{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:15:56Z","timestamp":1758125756466,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700837","81402247"],"award-info":[{"award-number":["81700837","81402247"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Axenfeld-Rieger syndrome (ARS) is an autosomal dominant disorder characterized by ocular anterior segment abnormalities. In the current study, we describe clinical and genetic findings in a Chinese ARS pedigree.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An ARS pedigree was recruited and patients were given comprehensive ophthalmic examinations and general physical examinations. DNA from the proband II:2 was used for exome sequencing. Sanger sequencing was utilized to identify and validate <jats:italic>PITX2<\/jats:italic> variations. qPCR and western blotting were performed to detect <jats:italic>PITX2<\/jats:italic> expression in immortalized peripheral blood lymphocytes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All affected family members showed typical ocular abnormalities, including iris atrophy, corectopia, shallow anterior chamber, complete or partial angle closure, and advanced glaucoma. They also exhibited systemic anomalies, such as microdontia, hypodontia, and redundant periumbilical skin. A heterozygous splice-site variation c.390\u2009+\u20091G\u2009&gt;\u2009A in <jats:italic>PITX2<\/jats:italic>, which might lead to a truncated PITX2 protein (p.Val131IlefsX127), was found in the proband. Sanger sequencing validated that the variation completely co-segregated with the ARS phenotype within this family and was absent in 100 unrelated controls. Western blotting revealed that the nuclear PITX2 protein was significantly decreased in patients compared with controls. Nonetheless, there was no significant difference in the total PITX2 protein level, consistent with qPCR results showing no alteration in <jats:italic>PITX2<\/jats:italic> mRNA levels in the patient group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p><jats:italic>PITX2<\/jats:italic> c.390\u2009+\u20091G\u2009&gt;\u2009A (p.Val131IlefsX127) was a novel genetic etiology of the ARS pedigree. The mutation leads to decreased nuclear <jats:italic>PITX2<\/jats:italic>, indicating lower transcriptional activity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10792-021-01704-5","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T11:06:46Z","timestamp":1611572806000},"page":"1503-1511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A PITX2 splice-site mutation in a family with Axenfeld-Rieger syndrome leads to decreased expression of nuclear PITX2 protein"],"prefix":"10.1007","volume":"41","author":[{"given":"Feng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lusi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengdan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanchu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"1704_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399405010082","volume":"7","author":"TA Hjalt","year":"2005","unstructured":"Hjalt TA, Semina EV (2005) Current molecular understanding of Axenfeld-Rieger syndrome. Expert Rev Mol Med 7:1\u201317","journal-title":"Expert Rev Mol Med"},{"key":"1704_CR2","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1101\/gad.11.16.2023","volume":"11","author":"J Kumar","year":"1997","unstructured":"Kumar J, Moses K (1997) Transcription factors in eye development: a gorgeous mosaic? Genes Dev 11:2023\u20132028","journal-title":"Genes Dev"},{"key":"1704_CR3","first-page":"1366","volume":"15","author":"K Kaur","year":"2009","unstructured":"Kaur K, Ragge NK, Ragoussis J (2009) Molecular analysis of FOXC1 in subjects presenting with severe developmental eye anomalies. Mol Vis 15:1366\u20131373","journal-title":"Mol Vis"},{"key":"1704_CR4","first-page":"19","volume-title":"Tumer Z","author":"N Weisschuh","year":"2011","unstructured":"Weisschuh N, De Baere E, Wissinger B (2011) Tumer Z. Axenfeld-Rieger syndrome. Eur J Hum Genet, Clinical utility gene card for, p 19"},{"key":"1704_CR5","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/ejhg.2012.80","volume":"20","author":"LM Reis","year":"2012","unstructured":"Reis LM, Tyler RC, Volkmann Kloss BA, Schilter KF, Levin AV, Lowry RB, Zwijnenburg PJ, Stroh E, Broeckel U, Murray JC, Semina EV (2012) PITX2 and FOXC1 spectrum of mutations in ocular syndromes. Eur J Hum Genet 20:1224\u20131233","journal-title":"Eur J Hum Genet"},{"key":"1704_CR6","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/odi.12894","volume":"24","author":"Y Yang","year":"2018","unstructured":"Yang Y, Wang X, Zhao Y, Qin M (2018) A novel 4q25 microdeletion encompassing PITX2 associated with Rieger syndrome. Oral Dis 24:1247\u20131254","journal-title":"Oral Dis"},{"key":"1704_CR7","first-page":"613","volume":"59","author":"JC Phillips","year":"1996","unstructured":"Phillips JC, del Bono EA, Haines JL, Pralea AM, Cohen JS, Greff LJ, Wiggs JL (1996) A second locus for Rieger syndrome maps to chromosome 13q14. Am J Hum Genet 59:613\u2013619","journal-title":"Am J Hum Genet"},{"key":"1704_CR8","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/cge.13148","volume":"93","author":"M Seifi","year":"2018","unstructured":"Seifi M, Walter MA (2018) Axenfeld-Rieger syndrome. Clin Genet 93:1123\u20131130","journal-title":"Clin Genet"},{"key":"1704_CR9","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/ejhg.2017.147","volume":"25","author":"E Souzeau","year":"2017","unstructured":"Souzeau E, Siggs OM, Zhou T, Galanopoulos A, Hodson T, Taranath D, Mills RA, Landers J, Pater J, Smith JE, Elder JE, Rait JL, Giles P, Phakey V, Staffieri SE, Kearns LS, Dubowsky A, Mackey DA, Hewitt AW, Ruddle JB, Burdon KP, Craig JE (2017) Glaucoma spectrum and age-related prevalence of individuals with FOXC1 and PITX2 variants. Eur J Hum Genet 25:1290","journal-title":"Eur J Hum Genet"},{"key":"1704_CR10","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754\u20131760. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324","journal-title":"Bioinformatics"},{"key":"1704_CR11","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1093\/hmg\/ddi365","volume":"14","author":"AL Evans","year":"2005","unstructured":"Evans AL, Gage PJ (2005) Expression of the homeobox gene Pitx2 in neural crest is required for optic stalk and ocular anterior segment development. Hum Mol Genet 14:3347\u20133359","journal-title":"Hum Mol Genet"},{"key":"1704_CR12","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1242\/dev.00849","volume":"130","author":"W Liu","year":"2003","unstructured":"Liu W, Selever J, Lu MF, Martin JF (2003) Genetic dissection of Pitx2 in craniofacial development uncovers new functions in branchial arch morphogenesis, late aspects of tooth morphogenesis and cell migration. Development 130:6375\u20136385","journal-title":"Development"},{"key":"1704_CR13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1161\/CIRCRESAHA.107.163188","volume":"102","author":"A Tessari","year":"2008","unstructured":"Tessari A, Pietrobon M, Notte A, Cifelli G, Gage PJ, Schneider MD, Lembo G, Campione M (2008) Myocardial Pitx2 differentially regulates the left atrial identity and ventricular asymmetric remodeling programs. Circ Res 102:813\u2013822","journal-title":"Circ Res"},{"key":"1704_CR14","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1128\/MCB.01848-06","volume":"27","author":"D Ai","year":"2007","unstructured":"Ai D, Wang J, Amen M, Lu MF, Amendt BA, Martin JF (2007) Nuclear factor 1 and T-cell factor\/LEF recognition elements regulate Pitx2 transcription in pituitary development. Mol Cell Biol 27:5765\u20135775","journal-title":"Mol Cell Biol"},{"key":"1704_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ydbio.2008.02.030","volume":"317","author":"PJ Gage","year":"2008","unstructured":"Gage PJ, Qian M, Wu D, Rosenberg KI (2008) The canonical Wnt signaling antagonist DKK2 is an essential effector of PITX2 function during normal eye development. Dev Biol 317:310\u2013324","journal-title":"Dev Biol"},{"key":"1704_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/hmg\/6.3.457","volume":"6","author":"PJ Gage","year":"1997","unstructured":"Gage PJ, Camper SA (1997) Pituitary homeobox 2, a novel member of the bicoid-related family of homeobox genes, is a potential regulator of anterior structure formation. Hum Mol Genet 6:457\u2013464","journal-title":"Hum Mol Genet"},{"key":"1704_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C","volume":"218","author":"TA Hjalt","year":"2000","unstructured":"Hjalt TA, Semina EV, Amendt BA, Murray JC (2000) The Pitx2 protein in mouse development. Dev Dyn 218:195\u2013200","journal-title":"Dev Dyn"},{"key":"1704_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/hmg\/ddl008","volume":"15","author":"FB Berry","year":"2006","unstructured":"Berry FB, Lines MA, Oas JM, Footz T, Underhill DA, Gage PJ, Walter MA (2006) Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis. Hum Mol Genet 15:905\u2013919","journal-title":"Hum Mol Genet"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01704-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-01704-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01704-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T18:10:01Z","timestamp":1617991801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-01704-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1704"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-01704-5","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"type":"print","value":"0165-5701"},{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"31 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Second Xiangya Hospital research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}